Strategies and rules for tuning TCR-derived therapy

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• T-cell manipulation has transformed cancer immunotherapy, with T-cell receptor (TCR)-engineered T cells (TCR-T) offering a promising avenue for solid tumor treatment.
• Significant hurdles remain, including limited clinical response, off-target effects, and the immunosuppressive tumor microenvironment, impeding widespread clinical application.

Purpose of the Study:

• To provide guidance for TCR-T investigators addressing key challenges in solid tumor treatment.
• To discuss critical considerations for optimizing TCR-T therapy, including affinity maturation, overcoming tumor-induced immunosuppression, and future therapeutic directions.

Main Methods:

• This is a review article, synthesizing current knowledge and expert perspectives.
• Key areas of focus include evaluating the necessity and criteria for affinity maturation of TCRs.
• Exploration of modifications to enhance T-cell function within the tumor microenvironment and assessment of their safety profiles.

Main Results:

• The review identifies critical decision points for TCR-T therapy development.
• It highlights strategies to improve T-cell persistence and function against solid tumors.
• It outlines potential future advancements and novel approaches in TCR-T cell therapy.

Conclusions:

• Optimizing TCR affinity and engineering T cells to resist the tumor microenvironment are crucial for enhancing TCR-T efficacy in solid tumors.
• Further research into novel modifications and therapeutic strategies is essential for advancing TCR-T cell therapy and realizing its full clinical potential.